Inicio87S • FRA
add
Roivant Sciences Ltd
Cierre anterior
9,72 €
Intervalo diario
9,79 € - 9,82 €
Intervalo anual
7,98 € - 12,11 €
Cap. bursátil
7881,15 M USD
Volumen medio
4,00
Relación precio-beneficio
-
Rentabilidad por dividendo
-
Bolsa de valores principal
NASDAQ
En las noticias
Información sobre la empresa
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
Director ejecutivo
Fundación
7 abr 2014
Sitio web
Empleados
908